Even after assuming GLP-1 price declines, CBO still said costs would far outnumber savings if Medicare covered the drugs for weight loss. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
